Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127117111 | 12711711 | 1 | I | 20160504 | 20160819 | 20160902 | 20160902 | EXP | GB-AUROBINDO-AUR-APL-2016-10838 | AUROBINDO | 40.00 | YR | M | Y | 83.00000 | KG | 20160902 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127117111 | 12711711 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 500 MG, TWO TIMES A DAY | 54958.332 | MG | U | U | 77859 | 500 | MG | BID | |||
127117111 | 12711711 | 2 | C | ALZAIN | 2 | Unknown | 1 DF, TWO TIMES A DAY | 94 | DF | U | 0 | 1 | DF | BID | |||||
127117111 | 12711711 | 3 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 1 DF, ONCE A DAY | 6 | DF | U | 0 | 1 | DF | QD | ||||
127117111 | 12711711 | 4 | C | DERMOL /01330701/ | 2 | Unknown | 1 DF, ONCE A DAY, OR WASHING. | 721 | DF | U | 0 | 1 | DF | QD | |||||
127117111 | 12711711 | 5 | C | PREGABALIN. | PREGABALIN | 1 | Unknown | 1 DF, TWO TIMES A DAY | 58 | DF | U | 0 | 1 | DF | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127117111 | 12711711 | 1 | Prostatitis |
127117111 | 12711711 | 2 | Product used for unknown indication |
127117111 | 12711711 | 3 | Product used for unknown indication |
127117111 | 12711711 | 4 | Product used for unknown indication |
127117111 | 12711711 | 5 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127117111 | 12711711 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127117111 | 12711711 | Abdominal pain | |
127117111 | 12711711 | Arthralgia | |
127117111 | 12711711 | Bradyphrenia | |
127117111 | 12711711 | Constipation | |
127117111 | 12711711 | Dermatitis contact | |
127117111 | 12711711 | Dyspnoea | |
127117111 | 12711711 | Fatigue | |
127117111 | 12711711 | Feeling abnormal | |
127117111 | 12711711 | Hair colour changes | |
127117111 | 12711711 | Heart rate increased | |
127117111 | 12711711 | Inguinal mass | |
127117111 | 12711711 | Insomnia | |
127117111 | 12711711 | Joint stiffness | |
127117111 | 12711711 | Malaise | |
127117111 | 12711711 | Muscle twitching | |
127117111 | 12711711 | Nausea | |
127117111 | 12711711 | Night sweats | |
127117111 | 12711711 | Palpitations | |
127117111 | 12711711 | Rash | |
127117111 | 12711711 | Suicidal ideation | |
127117111 | 12711711 | Vision blurred | |
127117111 | 12711711 | Vitreous floaters |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127117111 | 12711711 | 1 | 20160310 | 0 | ||
127117111 | 12711711 | 2 | 20160620 | 0 | ||
127117111 | 12711711 | 3 | 20160510 | 20160607 | 0 | |
127117111 | 12711711 | 4 | 20140514 | 0 | ||
127117111 | 12711711 | 5 | 20160602 | 20160603 | 0 |